About CBD International
A global distributor and developer of cannabis oil treatment series created for people managing cancer and chronic pain.
Who We Are
CBD International operates as a global distributor of cannabis oil treatments for cancer, working with families and individuals seeking alternative approaches to pain and disease management. The organization is the developer of the MR10P Series and the broader M-Series line of cannabis oil classifications.
Each series is built around specific cannabinoid concentrations, allowing treatment options to be considered on an individualized basis rather than a single fixed formula.
CBD International has built its reputation around the development of cannabis oil treatment series designed for individuals managing cancer and chronic pain. The organization's work centers on the MR10P Series and the broader M-Series line of cannabis oil classifications, each formulated with specific cannabinoid concentrations to allow for individualized treatment considerations. As a global distributor, the company collaborates with families and patients seeking alternative approaches to conventional therapies. The focus remains on providing options that may support the body's natural processes during cancer care, offering a complementary path alongside traditional medical protocols for those exploring integrative treatment strategies.
The approach taken by CBD International recognizes that each patient's journey with cancer presents unique challenges and underlying conditions. Their cannabis oil protocols are developed with attention to varying stages of illness, from early intervention through advanced care. The treatment series are designed to be considered alongside or as part of a broader care plan that may include dietary adjustments, immune support, and other complementary therapies. By offering a range of cannabinoid-based options, the organization aims to provide flexibility for patients and their physicians when evaluating potential courses of action for pain management, symptom relief, and overall quality of life during treatment.
Beyond the development of cannabis oil formulations, CBD International serves as a resource for families navigating the complexities of alternative cancer care. The organization provides educational materials and support for those seeking to understand the potential benefits and risks associated with cannabinoid therapies. Their work extends to connecting patients with information about ketogenic dietary approaches, DCA protocols, and other complementary strategies that may enhance conventional treatment outcomes. The emphasis remains on empowering individuals with knowledge and access to proven alternative options, supporting ongoing care from initial diagnosis through remission and long-term wellness management.
What We Focus On
- 1Distribution of cannabis oil treatments developed specifically for cancer-related conditions.
- 2Ongoing development of the MR10P Series and M-Series treatment classifications.
- 3Support for member wellbeing, with an emphasis on pain management alongside treatment.
Our Commitment
CBD International is committed to the wellbeing of the members it works with, keeping pain management at the center of how treatment series are developed and distributed. Locations associated with the organization include Valencia, Spain, and North America.
Those interested in learning more about the MR10P Series, M-Series, or related protocols can reach the team directly through our contact channels.
Information on this page describes CBD International's role as a distributor and developer of cannabis oil treatment series. It does not constitute medical advice, and no statement here should be read as a guarantee of outcome.